Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Clinical trial NCT06422143 · RECRUITING
Trial details
- NCT number
- NCT06422143
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2029-01-12
- Enrollment
- 851
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.